Surmodics Inc (SU6) Quote

Please don’t LIE to the board. They deserve better. I’ve only posted 7 days in June.

Yep it was a sell the news event when FDA approved label expansion. The hard work of building scripts was just to begin and the market wanted to see results.

Great report! Sounds like a very positive experience. Appreciate you taking the time to share! Look forward to hearing more.

Excellent post!!!

Cheers,

BB

I've had over a dozen biotech's sold to BP or ramp for P3 and approvals. Have worked in the biopharma industry of over 20 years and on the launch team for the most successful drug launch of the day. Also a new product strategy development consultant with over 12 of the leading BPs.

Georgie simply posts views of stock charts.
Dare I say with amazing accuracy too.
Good person and good luck also!

I ShortNaked🟩EVERYday-X MorganStanleyEmployee
“Gaming Wall Street”- HBO Documentary

Ex Morgan Stanley employee explains the situation about shorting and naked shorting perfectly!

Again, this is a MUST WATCH video for anyone who believes in shorting (n

This is a strong positive sign, transparency is getting some traction.
Get those questions ready… we can’t wait to answer them all!!!

!!!!! (( POST OF THE DAY )) !!!!!

You suck and have no conviction.

Really, that is what you are about?

What “composites” is KBLB working towards that would incorporate DS? Is there a difference between a composite fiber and a composite product or material? I went back and read a financial and “composites” just hangs out there as some thing or things they are working toward.

Are ya lookin’ in a mirror? If not, ya ought to be.

You refer to arm C as the “masking arm” but Ocular in the presentation (slides 54 and 61) calls it the “comparator arm”. I think you are right, the trial is comparing Axpaxli every 6 months to Eyelea every 8 weeks, so I don’t see why they call C the comparator. I assume the purpose of C is to mask

Again with the OTC 2021 nonsense? We all made money in the OTC in early 2021. Big whoop. You lost money in the OTC in 2022 and 2023 via charting because you are clueless and your charts don't work in the OTC, especially your charts.. Still waiting for those graphics of your OTC 20222 and 2023 g

AMDA you also said explore for alternative which implies they have to go looking for something, in desperation, instead of exploring options that might already be on the table. Yes they could have options already on the table with strategic partners. Youre purposefully changing what was said regardl

Strong close to end the week folks!

Looking for a nice bounce monday morning wonder if they will be ringing the bell oh hell don't matter but the volume will be awesome!

Dear Snow,
You are the eldest in our group -- Writing to seek your blessings here, noting with all excitement, we are acquiring the banking license -- This will not just solve many issues and we will be fixing the puzzle, it gives us enormous ability to generate revenue and conserve hefty fe

$DBMM litigated w/Kramers✅4theProtection ofShareholders+Mrkt✅
Asher Enterprises, Inc. has been sanctioned numerous times by the Commission for Securities §5 violations and, under information and belief, intends to commit further Securities Act §5 violations in DBMM's se

At this point who cares?

What I want to know is what are the chances Sharp gets indicted?

There's a long list of lies and manipulation.

This stock is dead.

Hopefully Tuesday. It’s up to their legal review and how long that actually takes. I’ll be happy if it’s posted by end of next week. Depending on what’s in the filing, I may sell off other tickers and put more into AAGC. Once the audit comes out, it will be hard getting shares.

LCJR

https://investorshub.advfn.com/uimage/uploads/2024/6/11/flgnvPINK_-_Copy.png